CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation. (Q48486771)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Fabian Docagne

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Miriam Hernangómez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Fernando G Correa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Frida Loría

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Miriam Mecha

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Paula M Iñigo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Richard O Williams

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

José Borrell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Carmen Guaza

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

31 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1437-1450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

CB2 receptors in the brain: role in central immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

The endocannabinoid system as a target for the treatment of neuronal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Complement components of the innate immune system in health and disease in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

The endocannabinoid system is modulated in response to spinal cord injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

An interaction between CD200 and monoclonal antibody agonists to CD200R2 in development of dendritic cells that preferentially induce populations of CD4+CD25+ T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Regulation of myeloid cell function through the CD200 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Presence and regulation of the endocannabinoid system in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Cannabinoids and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

The endocannabinoid system as a target for the treatment of neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Endocannabinoid signaling in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Distribution of the Immune Inhibitory Molecules CD200 and CD200R in the Normal Central Nervous System and Multiple Sclerosis Lesions Suggests Neuron-Glia and Glia-Glia Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

7 January 2021

Endocannabinoids control spasticity in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

7 January 2021

Therapeutic potential of CB2 targeting in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

7 January 2021

Anti-CD200R ameliorates collagen-induced arthritis in mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

7 January 2021

CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

7 January 2021

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

7 January 2021

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22366

7 January 2021

Identifiers

DOI

10.1002/GLIA.22366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22653796%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference